◆英語タイトル：Eiger BioPharmaceuticals Inc (EIGR) - Financial and Strategic SWOT Analysis Review
◆産業分野：Pharmaceuticals and Healthcare
Eiger BioPharmaceuticals Inc (Eiger) formerly Celladon Corp, is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of novel drugs for the treatment of orphan diseases. The company provides pipeline products such as Lonafarnib and Lambda, which are in Phase 2 trials used for the treatment of hepatitis delta virus infection; Exendin 9-39, a phase 2 program for post-bariatric hypoglycemia; Ubenimex, a phase 2 program for lymphedema and pulmonary arterial hypertension. It offers late-stage portfolio products candidates that potential to address diseases for which unmet medical services. Eiger provides clinical development and commercialization of broad range of therapeutics. The company offers post-bariatric hypoglycemia prevention services. Eiger is headquartered in Palo Alto, California, the US.
Eiger BioPharmaceuticals Inc Key Recent Developments
Mar 09,2021: Eiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Feb 23,2021: Eiger Announces Publication of Phase 2 PREVENT Study Results of Avexitide in Post-Bariatric Hypoglycemia in Journal of Clinical Endocrinology & Metabolism
Jan 07,2021: Eiger BioPharmaceuticals updates on 2020 progress and 2021 plans
Nov 05,2020: Eiger BioPharmaceuticals reports third quarter 2020 financial results and provides business update
Aug 06,2020: Eiger BioPharmaceuticals reports second quarter 2020 financial results and provides business update
This comprehensive SWOT profile of Eiger BioPharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Eiger BioPharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
Eiger BioPharmaceuticals Inc – Key Information
Eiger BioPharmaceuticals Inc – Overview
Eiger BioPharmaceuticals Inc – Key Employees
Eiger BioPharmaceuticals Inc – Key Employee Biographies
Eiger BioPharmaceuticals Inc – Key Operational Heads
Eiger BioPharmaceuticals Inc – Major Products and Services
Eiger BioPharmaceuticals Inc – History
Eiger BioPharmaceuticals Inc – Company Statement
Eiger BioPharmaceuticals Inc – Locations And Subsidiaries
Eiger BioPharmaceuticals Inc
Other Locations & Subsidiaries
Section 2 – Company Analysis
Eiger BioPharmaceuticals Inc – Business Description
Eiger BioPharmaceuticals Inc – Corporate Strategy
Eiger BioPharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Eiger BioPharmaceuticals Inc – Strengths
Eiger BioPharmaceuticals Inc – Weaknesses
Eiger BioPharmaceuticals Inc – Opportunities
Eiger BioPharmaceuticals Inc – Threats
Eiger BioPharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Performance Charts
Eiger BioPharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
Eiger BioPharmaceuticals Inc, Key Information
Eiger BioPharmaceuticals Inc, Key Ratios
Eiger BioPharmaceuticals Inc, Share Data
Eiger BioPharmaceuticals Inc, Major Products and Services
Eiger BioPharmaceuticals Inc, History
Eiger BioPharmaceuticals Inc, Key Employees
Eiger BioPharmaceuticals Inc, Key Employee Biographies
Eiger BioPharmaceuticals Inc, Key Operational Heads
Eiger BioPharmaceuticals Inc, Other Locations
Eiger BioPharmaceuticals Inc, Subsidiaries
Eiger BioPharmaceuticals Inc, Key Competitors
Eiger BioPharmaceuticals Inc, SWOT Analysis
Eiger BioPharmaceuticals Inc, Ratios based on current share price
Eiger BioPharmaceuticals Inc, Annual Ratios
Eiger BioPharmaceuticals Inc, Interim Ratios
Capital Market Ratios
| ★海外企業調査レポート[Eiger BioPharmaceuticals Inc (EIGR)：企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら